Crossmark

ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR

Published Online: 2020-09-16

Published Print: 2021-04

Authors

Wan, H. https://orcid.org/0000-0002-3873-1736
Li, Z. https://orcid.org/0000-0002-3656-7485
Wang, H. https://orcid.org/0000-0001-7957-7088
Cai, F. https://orcid.org/0000-0002-2090-546X
Wang, L. https://orcid.org/0000-0002-4003-784X
Funding

Funding for this research was provided by:

Hainan Provincial Natural Science Foundation of China (814315)
License Information

Text and Data Mining valid from 2020-09-16

Version of Record valid from 2020-09-16
More Information

Article History

Received: 2 May 2020

Accepted: 31 August 2020

First Online: 16 September 2020

Compliance with ethical standards

:

: The author(s) declare that they have no competing interests.

: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.

: Informed consent was obtained from all individual participants included in the study.

Document is current